Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-Time Soft Tissue Deformation Framework for Haptic-Enabled Robotic Surgical Training in Virtual Reality.

Annals of biomedical engineering·2026
Same author

A review of recent methods and applications of virtual fixtures in robot-assisted surgery.

Computers in biology and medicine·2025
Same author

Full-area three-element Risley prism system based on high precision real-time continuous scanning strategy.

Optics express·2025
Same author

Longitudinal-Torsional Frequency Coupling Design of Novel Ultrasonic Horns for Giant Magnetostrictive Transducers.

Sensors (Basel, Switzerland)·2024
Same author

Eddy Current-Based Identification and Depth Investigation of Microdefects in Steel Filaments.

Sensors (Basel, Switzerland)·2024
Same author

Development of a Large-Range XY-Compliant Micropositioning Stage with Laser-Based Sensing and Active Disturbance Rejection Control.

Sensors (Basel, Switzerland)·2024

Related Experiment Video

Updated: Jul 5, 2026

Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres
09:31

Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres

Published on: November 5, 2016

Medical nanorobotics for diabetes control.

Adriano Cavalcanti1, Bijan Shirinzadeh, Luiz C Kretly

  • 1CAN Center for Automation in Nanobiotech, Melbourne VIC, Australia. adrianocavalcanti@canbiotechnems.com

Nanomedicine : Nanotechnology, Biology, and Medicine
|May 6, 2008
PubMed
Summary

This study introduces a novel nanorobot system for diabetes management, utilizing nanobioelectronics for in vivo health monitoring. The system enables physicians to help patients avoid hyperglycemia using a smartphone-based communication device.

More Related Videos

Folding and Characterization of a Bio-responsive Robot from DNA Origami
07:59

Folding and Characterization of a Bio-responsive Robot from DNA Origami

Published on: December 3, 2015

Hollow Microneedle-based Sensor for Multiplexed Transdermal Electrochemical Sensing
08:19

Hollow Microneedle-based Sensor for Multiplexed Transdermal Electrochemical Sensing

Published on: June 1, 2012

Related Experiment Videos

Last Updated: Jul 5, 2026

Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres
09:31

Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres

Published on: November 5, 2016

Folding and Characterization of a Bio-responsive Robot from DNA Origami
07:59

Folding and Characterization of a Bio-responsive Robot from DNA Origami

Published on: December 3, 2015

Hollow Microneedle-based Sensor for Multiplexed Transdermal Electrochemical Sensing
08:19

Hollow Microneedle-based Sensor for Multiplexed Transdermal Electrochemical Sensing

Published on: June 1, 2012

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Medical Instrumentation

Background:

  • Advancements in nanobioelectronics, wireless communication, and materials science are driving the development of nanorobots for therapeutic applications.
  • Diabetes management requires continuous monitoring and intervention to prevent complications like hyperglycemia.

Purpose of the Study:

  • To present an innovative nanorobot architecture based on nanobioelectronics for diabetes management.
  • To illustrate the integrated circuit architecture and layout of the nanorobot system.
  • To demonstrate the feasibility of a practical medical nanorobotics platform for in vivo health monitoring.

Main Methods:

  • A computational approach was used to simulate the nanorobot integrated circuit architecture and layout.
  • The simulation incorporated clinical data for medical nanorobotics application in diabetes.
  • A 3D prototyping model was developed for physician-patient interaction via a handheld device.

Main Results:

  • The proposed architecture integrates sensing, hardware design, manufacturing analysis, and control investigation.
  • Simulations demonstrated the potential for interactive tools to guide nanorobot selection and control.
  • A handheld device enables communication with nanorobots for real-time patient management.

Conclusions:

  • The developed nanorobot architecture offers a viable platform for practical medical nanorobotics.
  • This technology has the potential to significantly improve in vivo health monitoring and diabetes care.
  • The system facilitates physician-assisted avoidance of hyperglycemia through remote communication with nanorobots.